Mucin containing ophthalmic preparations

• US 6,281,192 B1
• Filed: 03/01/2000
• Issued: 08/28/2001
• Est. Priority Date: 03/01/1999
• Status: Expired due to Fees

• Current Assignee: University of Utah (State of Utah), University of Utah Research Foundation (State of Utah), Vista Scientific, LLC
• Original Assignee: Vista Scientific, LLC
• Inventors: Ellis, Jeanne Y., Leahy, Charles D., Ellis, Edward J.
• Primary Examiner(s): FAY, ZOHREH A
• Application Number:
  US09/516,671
• Time in Patent Office: 545 Days
• Field of Search: 424/95, 424/104, 514/912, 514/8
• US Class Current: 514/20.8
• CPC Class Codes: A61K 38/1709 from mammals
• CPC Class Codes: A61K 9/0048 Eye, e.g. artificial tears
• CPC Class Codes: A61P 27/02 Ophthalmic agents

Abstract

The present invention discloses the ophthalmic applications of mucin derived from mammalian milk or milk byproducts. This mucin has been found to be a MUC1 type mucin similar to the transmembrane mucin expressed on the surface of the human eye. The mucin-containing preparations described in this invention can be in the form of an aqueous formulation to be instilled into the eye, or in which to pre-soak or store an object to be inserted into the eye, such as a contact lens, an ointment, or a solid device to be inserted into the conjunctival sac. The preparations disclosed are utilized for the treatment of tear film and ocular surface disorders associated with the signs and symptoms of dry eye. Furthermore, mucin-based formulations are also effective for the relief of symptoms of eye irritation, such as those caused by environmental conditions or by contact lens wear.

Claims

1. An ophthalmic preparation comprising a mucin-containing component derived from mammalian milk or a milk byproduct, wherein said mucin-containing component is classified as a MUC1 type mucin.

2. An ophthalmic preparation in accordance with claim 1 wherein said preparation is in the form of a solution.

3. An ophthalmic preparation in accordance with claim 1 wherein said preparation is in the form of an ointment.

4. An ophthalmic preparation in accordance with claim 1 wherein said preparation is in the form of a gel.

5. An ophthalmic preparation in accordance with claim 1 wherein said preparation is in the form of an ocular insert.

6. An ophthalmic preparation in accordance with claim 1 wherein the mucin-containing component comprises at least 20% mucin by weight.

7. An ophthalmic preparation in accordance with claim 1 wherein the mucin-containing component is present in an amount from about 0.001% to about 1.0% by weight.

8. An ophthalmic preparation in accordance with claim 1 wherein the mucin-containing component is present in an amount from about 1.0% to about 10.0% by weight.

9. An ophthalmic preparation in accordance with claim 1 wherein the mucin-containing component is present in an amount from about 10% to about 90% by weight.

10. An ophthalmic preparation in accordance with claim 1 further comprising a buffering agent.

11. An ophthalmic preparation in accordance with claim 1 further comprising a viscosity modifying agent.

12. An ophthalmic preparation in accordance with claim 1 further comprising a tonicity modifying agent.

13. An ophthalmic preparation in accordance with claim 1 further comprising a humectant compound.

14. An ophthalmic preparation in accordance with claim 1 further comprising a therapeutic drug.

15. An ophthalmic preparation in accordance with claim 1 further comprising a buffering agent plus a viscosity modifying agent.

16. An ophthalmic preparation in accordance with claim 1 wherein said milk byproduct comprises whey.

17. An ophthalmic preparation in accordance with claim 16, wherein said whey is purified to recover said mucin component.

18. An ophthalmic preparation for treating an eye by topically applying the preparation to an ocular surface to provide lubrication and protection to the ocular surface for the relief of dryness and discomfort symptoms, the ophthalmic preparation comprising:

a buffered, sterile aqueous solution including a mucin-containing component, wherein said mucin-containing component is derived from mammalian milk or a milk byproduct and is classified as a MUC1 type mucin.

19. An ophthalmic preparation in accordance with claim 18, wherein said milk byproduct comprises whey, said whey being purified to recover said mucin component.

20. An ophthalmic preparation in accordance with claim 18, wherein said mucin-containing component is classified as a MUC1 type mucin.

21. An ophthalmic preparation comprising a mucin-containing component derived from mammalian milk or a milk byproduct, said preparation including said mucin-containing component being autoclavable.

22. An ophthalmic preparation in accordance with claim 21, wherein said mucin-containing component is classified as a MUC1 type mucin.

23. An ophthalmic preparation in accordance with claim 21, wherein said mucin-containing component is formed of an isolated, purified MUC1 type mucin.

24. An ophthalmic preparation in accordance with claim 21, wherein said mucin-containing component is formed entirely of mucin having a single mucin classification.

25. A method of treating an eye for dryness and other discomfort symptoms, the method comprising:

preparing a buffered, sterile aqueous solution including a mucin-containing component, wherein said mucin-containing component is derived from mammalian milk or a milk byproduct and is classified as a MUC1 type mucin; and

topically applying said solution to an ocular surface of the eye.